Abstract Calcium (Ca 2+ ) has long been recognized as a crucial intracellular messenger attaining stimuli-specific cellular outcomes via localized signaling. Ca -CaM-dependent protein kinase (CaMKII) signaling events but also highlights the outstanding challenges in the field.
Introduction

Intracellular Ca
2+ is a quintessential intracellular messenger, and many of its cellular effects are transduced by calmodulin (CaM). The spatiotemporal characteristics of these intracellular Ca 2+ signals hinge on a complex interplay between Ca 2+ influx and efflux mechanisms, mobile vs. stationary Ca 2+ -binding proteins (such as CaM) and intracellular localization/partitioning or sequestration. Over the past decades, great strides have been made in understanding the local control mechanisms underlying the global Ca 2+ oscillations (ranging from 0.1 to 1 μM) in the beating heart [1] . It has also become clear that multiple Ca 2+ signaling events, independent of those governing cardiac contraction, occur simultaneously in the same myocyte and control myriad cellular outcomes [2] . Several microdomain Ca 2+ signals leading to altered transcription have now been identified, e.g., caveolae-localized L-type Ca channels provide the Ca 2+ source for the Ca 2+ -CaM-dependent activation of calcineurin-nuclear factor of activated T cell (NFAT) signaling, and inositol triphosphate receptors (InsP 3 R) that release Ca 2+ can activate Ca 2+ -CaM-dependent kinase (CaMKII) related to histone deacetylase (HDAC) signaling [3, 4] . Here, we report how recent advances in fluorescent biosensors can provide unique insights into the spatiotemporal dynamics of these local Ca
2+
-CaM signals, how they are sensed and decoded to shape particular cellular responses. central α helix flanked by two globular lobes (the N-and Clobes) [5, 6] . Each lobe contains two coupled EF-hand motifs with the C-lobe having higher Ca 2+ binding affinity (K d ≈1 μM) than the N-lobe (K d ≈12 μM) [7] [8] [9] . The lobes also differ in Ca 2+ dissociation kinetics (∼1,000 s −1 for the N-lobe and 100 times slower for the C-lobe). Upon Ca 2+ binding, CaM undergoes a profound conformational change (becoming a more elongated structure), modulating the interaction with its target proteins [10] . The structural flexibility of CaM explains the abundance and structural heterogeneity of CaM interacting proteins or interactome [11] [12] [13] [14] . These CaM-binding targets differ in their preference for apoCaM, and Ca 2+ -CaM can be activated or inhibited upon CaM binding and can themselves influence Ca 2+ sensitivity of CaM [15, 16] . Target proteins of note in the heart include ion channels (L-type Ca channels (LTCC) [17] ), ryanodine receptors (RyR) [18] , InsP 3 R [19] , the protein phosphatase calcineurin (CaN) [16] , CaMKII, nitric oxide synthase, adenylyl cyclase (AC), phosphodiesterase (PDE), myosin light chain kinase (MLCK), etc. [20] .
In vivo, CaM tethering to target proteins can be monitored with fluorescence resonance energy transfer (FRET), even with simultaneous [Ca 2+ ] using Ca 2+ indicators [21] . Our group used a variant of this approach in adult cardiac myocytes to map CaM binding to the RyR by monitoring FRET between fluorescently labeled FKBP12.6 bound to RyR and fluorescent CaM [22] . CaM binding was found to stabilize the zipped conformational state of the RyR (reducing RyR activation). Interdomain "unzipping" of the RyR by treating the cells with a peptide DPc10 that mimics one of the zipped regions, also reduced CaM binding and enhanced RyR gating, Ca 2+ sparks and waves that favor arrhythmogenic events and unloading Ca 2+ from the sarcoplasmic reticulum (SR), thereby mimicking aberrant channel activation as seen in heart failure [23].
CaM (trans)location and availability Surprisingly, data regarding CaM location and redistribution remain scarce in adult cardiomyocytes. Total CaM concentration is ∼6 μM in isolated cardiac myocytes [24] , and at resting [Ca 2+ ] levels, most CaM is apoCaM (not Ca 2+ bound). Some of this apoCaM is already prebound to targets as structural elements of the protein or is poised nearby the target awaiting local activation (part of the signaling scaffold). Using null-point titration methods with fluorescently labeled CaM, Wu ] i ), most intracellular CaM is bound to cellular constituents and appears highly localized to the Z line (or transverse tubule) (Fig. 1) ] is elevated (from 100 to 500 nM), more CaM is bound at the Z lines (where the junctional SR is), and from which CaM dissociation is extremely slow, but there is also a significant translocation of CaM into the nucleus [26] . Normal twitch Ca 2+ oscillations did not trigger this nuclear redistribution [4] . This indicated that the kinetics of Ca 2+ -CaM signaling may be critical for this CaM translocation. Endothelin-1 binding to its G-protein-coupled receptor (GPCR) also causes nuclear translocation of CaM, without triggering a detectable elevation of global [Ca 2+ ] i [4] . Analogous to the RyR environment above, it is possible that CaM at or near InsP 3 R downstream of endothelin-1 might stimulate this CaM translocation. So, chronic global Ca 2+ elevation can trigger nuclear CaM accumulation, but certain local Ca 2+ signals can achieve the same effect. Changes in nuclear CaM are likely to be of pathophysiological importance given its regulation of nuclear CaMKII activity (see below), but also because of direct effects on myocyte enhancer factor 2-dependent transcription [30] . In neurons, nuclear CaM was also shown to affect phosphorylation of cAMP response element binding protein [31] . How CaM translocates to the nucleus in cardiomyocytes remains to be identified [32] . In neurons, this nuclear import occurs in association with partner proteins [33] , and this is probably also true in the heart given the low free CaM levels (and competition Concept of "dedicated" vs. "promiscuous" CaM An emerging theme for CaM modulation of ion channels in cardiac myocytes is the multiple modes of regulation mediated by distinct functional populations of CaM ( Fig. 1 ): a dedicated pool of CaM typically tethered to the channels, which directly regulates channel activity (most often involved in inactivation), and a more promiscuous pool of CaM poised nearby to transduce local Ca 2+ signals via activation of downstream effectors such as CaN and CaMKII (providing a negative or positive feedback loop). These intricate levels of CaM regulation of channel function were recently reviewed in detail [38] for the L-type Ca 2+ channel, the ryanodine receptor, and the InsP3 receptor but are beyond the scope of this review. In general, the mechanisms of promiscuous CaM regulation are less clear, but from an imaging perspective, several of the remaining questions can be addressed such as: is this promiscuous CaM activated to act locally or does it diffuse from more distant sources? Are the Ca 2+ signals transduced by the dedicated (tethered) and promiscuous (more global) CaM the same? What is the reservoir/source of this promiscuous CaM pool (e.g., which proteins release CaM with Ca 2+ influx)? Several of these events are likely happening within the single resolvable volume of traditional confocal microscopy. The technical challenge to overcome here is the spatial resolution limitation, and this may require novel experimental approaches or a combination thereof: total internal reflection fluorescence microscopy which limits the fluorescence signal to ∼100 nm from the coverslip, FRET imaging of dynamic protein interactions, subcellular targeting of biosensors, super resolution fluorescence microscopy (PALM and STORM). (Fig. 2) . These different behaviors could also be predicted quantitatively from a myocyte model [46, 47] which implies that differences in Ca 2+ -CaM affinities of CaM target proteins provide an important mechanism for accomplishing the CaM signaling diversity and complexity: Ca-CaM affinity confers specific Ca 2+ -decoding ability to the CaM target protein thereby fine-tuning the cellular response.
Targeted versions of these biosensors are currently being used by our group to verify model projections of how local CaM signals might regulate CaMKII and CaN [47] . While large Ca 2+ -CaM oscillations are predicted to occur at the dyadic cleft on a beat-to-beat basis, the extensive CaM buffering and lower cytosolic Ca 2+ would minimize the CaCaM fluctuations there. For CaMKII, this would mean not only beat-dependent oscillations of activity in the dyadic cleft but also very little activation of CaMKII in the bulk cytosol because of the limited CaM signals in that compartment. It is hard to reconcile this prediction with known CaMKIIdependent phosphorylation of cytosolic targets such as phospholamban, although this may be why CaMKII is routinely anchored nearby its targets-and might have a nearby pool of promiscuous CaM. CaN activity on the other hand is predicted to be frequency dependent in the cytosol and saturated in the dyad. This is consistent with observations that CaN/NFAT signaling correlates closely to global Ca 2+ oscillation [48, 49] . Since CaN is tethered to LTCCs [50] , it will be important to assess whether CaN activity at the dyad is indeed constitutively active or remains somewhat dynamically regulated by Ca 2+ signals.
CaMKII: a multifunctional kinase
While CaMKII is uniquely adapted to sense, integrate, and transduce cellular Ca 2+ (and Ca 2+ -CaM) signals, it is much more than merely a CaM effector. CaMKII is a key regulator of cardiac excitation-contraction coupling via its effects on ion channels and Ca 2+ handling proteins, but is also important for more chronic cardiac responses via regulation of gene expression. Aside from this physiological role, CaMKII is also critically involved in the development of arrhythmias and heart failure. Several reviews have highlighted the role of CaMKII in various pathophysiological conditions and its potential as a therapeutic target [51] [52] [53] [54] [55] [56] [57] [58] .
Biochemistry of CaMKII
CaMKII is unique among protein kinases because it forms a dodecameric holoenzyme. It is encoded by four different genes (α, β, δ, and γ) [59, 60] . Of these, CaMKIIδ is the predominant cardiac isoform, and two splice variants are known to be present in the heart (δ B and δ C ). Each subunit of the holoenzyme consists of a serine/threonine-specific catalytic domain followed by a regulatory segment that binds Ca 2+ -CaM (Fig. 3 ). The latter is followed by a flexible linker of variable length (isoform-specific) that connects to the association or hub domain. The association domains assemble the subunits into two stacked hexameric rings. FRET experiments, where the catalytic domain was replaced with CFP or YFP, showed that CaMKII freely hetero-oligomerizes and that the variable linker influences the distance between N-termini [61] . The recent crystal structure of the auto-inhibited CaMKII holoenzyme indicated that this variable linker also provides a fine-tuning mechanism of the holoenzyme Ca 2+ response: the variable linker alters the equilibrium between compact and more open docking states of the kinase domains against the central hub (with the CaM binding sites more accessible for the longer linkers) [62] . Indeed, different isoforms display slightly altered sensitivities to Ca 2+ [63] , but how this translates to signal diversity in the cardiomyocyte remains to be established.
At baseline, CaMKII is in an auto-inhibited state where the catalytic domain is constrained by the pseudosubstrate region within the regulatory domain [64] (Fig. 3a-b [53] .
Localization of CaMKII
CaMKII isoforms differ in subcellular targeting as well as interacting partners [68] [69] [70] and is purported as a key aspect of isoform signal specificity. In the heart, the CaMKII δ B and δ C subtypes differ only by the presence of a nuclear localization sequence and are thought to preferentially localize accordingly: δ B mainly nuclear and δ C mainly cytosolic [71] [72] [73] . Different functions had been attributed to each isoform, with nuclear δ B involved in hypertrophic gene regulation and cytosolic δ C in regulation of ion channels and Ca 2+ handling. Initial findings in transgenic mice supported this since CaMKII δ B transgenics develop cardiac hypertrophy, but this hypertrophy rapidly transitions to heart failure in the CaMKIIδ C mice (with extensive Ca 2+ handling dysfunction) [73] [74] [75] [76] [77] . However, all CaMKII isoforms (α-δ, including these splice variants) appear to hetero-multimerize [61] which can explain in part why CaMKIIδ B is not restricted to the nucleus and CaMKIIδ C is not exclusively cytosolic [78] . Indeed, CaMKIIδ B and δ C were found to have similar effects on MEF2 modulation and gene expression, but initially, this was attributed to direct effects of CaMKIIδ B and δ C subtypes on HDAC in the nucleus and cytosol, respectively [79] . More recently, Mishra et al. [78] upset this traditional dogma of isoform-specific location and postulated that spatial and functional specificity of CaMKIIδ activation is obtained by mobilization of different Ca 2+ stores [78] . This was based on their findings that even when expressed in CaMKIIδ null background, CaMKIIδ B and δ C subtype targeting remained nonexclusive, and both subtypes had compartment-specific activation profiles: a phenylephrine stimulus triggered nuclear CaMKIIδ activation and HDAC phosphorylation, whereas caffeine elicited cytosolic CaMKIIδ activation and phospholamban phosphorylation. To what extent these findings will impact the notion of CaMKII δ B as having a cardioprotective role and δ C as having a more deleterious role in cardiomyocyte survival and heart disease [80] [81] [82] [83] remains to be established. It is clear that CaMKII location matters and several direct interactions of CaMKII with target proteins have been described such as with the RyR [74, 84] , InsP 3 R [85] , LTCC subunits [28, 29] , and mitochondria [86] . Indeed, CaMKII overexpression potentiates SR Ca 2+ release and also enhances mitochondrial Ca 2+ uptake that can contribute to cell death [87] . Localization poises CaMKII near both local Ca 2+ pools and a signaling microdomain, thereby achieving signal specificity (e.g., the InsP 3 R-CaMKII-HDAC signaling pathway [4] ). This direct interaction pattern of CaMKII is in contrast to the scaffolding protein interactions found for PKA (Akinase anchoring proteins) [88] ). However, α kinase anchoring protein was found to serve as an "anchoring" protein for SERCA and CaMKII, positioning CaMKII for modulating PLB phosphorylation [89] . To what extent these interacting proteins modulate CaMKII function is still unclear. In neurons, α-actinin can act as a Ca 2+ -independent surrogate for CaM binding to CaMKII and also modulates CaMKII phosphorylation of specific substrates (such as glutamate receptor) [90] . In essence, α-actinin acted as a "phosphostat" CaMKII interactions, localization, and translocation are altered in cardiac disease.
Imaging CaMKII activity and regulation
Until recently, the tools for measuring CaMKII activation in cardiomyocytes were very limited and destructive. These included snapshot measurements of CaMKII modifications (i.e., its autophosphorylation or oxidation state using Western blotting or immunocytochemistry) or CaMKII target phosphorylation and kinase assays in cell lysate ( 32 P incorporations or fluorescence quenching). The Hayashi group developed Camui to study CaMKII activation in neurons [91] . This FRET-based biosensor consists of the full-length kinase flanked by the CFP/YFP fluorophores and takes advantage of the conformational changes of the kinase associated with activation. It is a powerful tool for detecting subtle, subcellular differences in CaMKII activation, so our group adapted it for use in cardiomyocytes [92] . The donor/acceptor fluorescence ratio (F CFP /F YFP ) of Camui is a good reporter of CaMKII activation by Ca 2+ -CaM, autophosphorylation, and oxidation (since all result in an opening of the regulatory and catalytic CaMKII domains). That is, Camui is more than a readout of Ca 2+ -CaM binding dynamics to cellular CaMKII (which could be inferred from the BsCaM responses), it is a direct readout of the active conformation of the kinase.
It should be noted that although the Camui response is fairly linear over a wide range for autonomous CaMKII activity (via phosphorylation or oxidation), direct Ca 2+ -CaM activation produces a stronger FRET change for a given amount of enzyme activity. A second limitation is that the Camui FRET is not simple bimolecular FRET but incorporates a structural element (the CFP on the catalytic domain can interact with more than one YFP on the association domain). This may contribute to some nonlinearity in F CFP /F YFP increase as catalytic domains become activated. Nonetheless, Camui is a good proxy for CaMKII activity. It can track both temporal and spatial changes in CaMKII activity in vivo and has the added benefit that the specific contributions of autophosphorylation and oxidation to CaMKII activation can be examined using Camui constructs lacking the target sites for these modifications. This makes Camui uniquely suited to study the subcellular mechanisms driving CaMKII signaling pathways in cardiomyocytes. Indeed, initial experiments showed that while there is a significant role for oxidative activation of CaMKII in response to angiotensin II and endothelin-1 exposure, the isoproterenoland phenylephrine-triggered activation of CaMKII was largely Ca-CaM and somewhat autophosphorylation dependent.
Camui studies examining the sensitivity of CaMKII function to varying beat-to-beat global Ca 2+ signals are already ongoing, as are experiments assessing how CaMKII responds to multiple spatially unique Ca 2+ signal inputs (global cytosolic Ca 2+ and GPCR-linked signals). Improvements to the Camui sensor also continue to be made [93, 94] : alternate CaMKII isoforms, improved FRET pairs, etc. An alternative to the Camui-style biosensors is a surrogate substrate-based reporter (Kinase Activity Reporter family (KAR), [95] ) where a forkhead association domain triggers a molecular switch upon phosphorylation by the target kinase, and this would induce changes in fluorescence intensities of the FRET fluorophores. These KARs have the added benefit that they can be subcellularly targeted to signaling microdomains providing even more detailed spatial information of kinase function. Future studies combining Camui and various models of cardiac disease are likely to provide extensive mechanistic insight into how CaMKII signaling contributes to arrhythmias and heart failure.
Concluding remarks and future perspectives
Numerous studies have shown that Ca 2+ -CaM-CaMKII signaling has a critical role in the regulation of both acute excitation-contraction and chronic excitation-transcription coupling in the heart. There is also abundant evidence that CaMKII has a ubiquitous role in pathophysiological conditions of the heart. Several fundamental questions regarding the signal processing and spatial intricacies of CaM/CaMKII signaling were highlighted here and deserve further investigation. The new generation of biosensors also provides unique opportunities to delineate the role and regulatory mechanisms of CaM and CaMKII in normal and diseased hearts. This will greatly benefit future efforts to design effective therapeutics targeted at cardiac CaMKII. 
